Op-Ed: Does Your Patient Really Have Diastolic Dysfunction? The Skeptical Cardiologist highlights the confusion in "diastology" Jun 05, 2021
Medtronic's LVAD Pulled From Market Due to Neurological, Mortality Risks Physicians must stop implanting the HeartWare system, says FDA Jun 03, 2021
Passing Early-Term Report Cards for New Mitral, Tricuspid Valve Interventions A glance at devices coming down the structural heart pipeline in the coming years May 24, 2021
Navitor Shuts Out Leaky TAVR, but Pacemaker Rates a Concern? 30-day data for a new version of the Portico valve May 20, 2021
Adverse Events Drop With Fuller Accounting of Evolut Low Risk Trial Yet worrying signals with TAVR remain May 19, 2021
Novel Heart Failure Agent Works Best in Sickest Patients Omecamtiv mecarbil provides benefit to those with low LVEF May 18, 2021
Entresto Risky for Advanced Heart Failure? LIFE trial "not only disappointed but surprised" with its findings May 17, 2021
Pacemaker Interference Warning; Religious Fasting and CVD; Toothpick in the Heart Recent developments of interest in cardiovascular medicine May 17, 2021
Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedback Guideline-directed medical therapy underuse still a problem in CONNECT-HF trial May 17, 2021
Personalized Rehab Helpful in Heart Failure Patients Trial showed improvements in physical functioning and quality of life compared with usual care May 17, 2021
Mixed Results with ARNI Therapy for Post-MI Heart Failure Prevention Sacubitril/valsartan deemed safe, but still can't beat ramipril in PARADISE-MI trial May 15, 2021
Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy Secondary findings show big gains for more than a third of patients May 15, 2021
ARNI Therapy in the Hot Seat at Another Virtual ACC PARADISE-MI to provide data on Entresto for MI survivors with reduced LVEF May 14, 2021
COVID Vax & Myocarditis; Ejection Fractions on EKG; Southerners Still Unwell Recent developments of interest in cardiovascular medicine May 10, 2021
Toxic Cardiology Culture Pervasive Worldwide, ACC Survey Finds No group was immune to hostile work conditions, but women and young doctors got the worst of it May 10, 2021
Surgical Repair: A Newcomer in Aortic Valve Disease In this podcast, Andrew Perry and Chris Burke tackle the current state of aortic valve repair May 07, 2021 podcast
What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
Farxiga Gets FDA Greenlight for CKD SGLT2 OK'd to prevent chronic kidney disease progression and cardiovascular risks Apr 30, 2021
Low Radiation Possible During Cardiac Cath in Children NYC center reports encouraging results with ALARA radiation protocol Apr 30, 2021
Endocarditis After Low-Risk TAVR: Different Trajectory, Problem Organisms Low-risk patients "not immune" to rare infection, LRT studies show Apr 30, 2021
Heart Pump Protocol Makes a Dent in Cardiogenic Shock Mortality NCSI algorithm includes early hemodynamic support Apr 29, 2021
Post-MitraClip Gradients Not So Dangerous After All COAPT analysis suggests benefit of MR reduction offsets risk of mitral stenosis Apr 19, 2021
CaMKII Inhibitor Disappoints in Post-MI Cardioprotection First agent of its kind to test the waters in heart disease Apr 14, 2021
Donor Heart Preserver Survives Review by FDA Advisors Panel had many bones to pick with the Transmedics OCS device Apr 07, 2021
Stripped of Hospital Privileges, St. Louis Cardiologists Go to Court Suit against SSM Health seeks $50 million if former status not restored Apr 02, 2021
Harmony Pulmonary Valve Gets FDA Nod Transcatheter valve implantation approved for people without surgical RVOT conduits Mar 26, 2021
DOAC After Heart Valve Procedure? Registry defines prevalent use with mechanical and bioprosthetic valves Mar 08, 2021
Pre-TAVR Leaflet Cut Backed by Registry BASILICA procedure for people at risk of coronary obstruction Mar 06, 2021
Universal Definition of Heart Failure Proposed U.S., European, and Japanese societies seek to standardize classifications Mar 02, 2021
Low-Risk TAVR at 2 Years: Thrombosis Concerns Creep In PARTNER 3 showing trends toward convergence of outcomes with surgery Mar 01, 2021
White Bread or White Rice? Glycemic Index Telling of CVD Risk Across Borders Observational study suggests role of diet in primary, secondary prevention alike Feb 24, 2021
ACC Report: Cardiac Care Better Woman-to-Woman Group suggests rethink of cardiology culture and medical education Feb 22, 2021
Drinks, Drugs and Smokes Spell Early Heart Disease Amphetamines, cannabis, and cocaine posed the greatest ASCVD risk in the young Feb 16, 2021
First Drug Approved for Some HFpEF FDA doesn't set hard limits on ejection fraction in expanded indication Feb 16, 2021
Heart Failure Drug Tempers Heart Rate, Symptoms in POTS Promising results for people with hyperadrenergic subtype of the complex disorder Feb 16, 2021
HIIT for HFpEF? Results Mixed in Exercise Trial Boosting intensity not obviously helpful Feb 09, 2021
Nutrition Status Tied to TAVR Outcomes Data support pre- and post-TAVR dietary interventions for the elderly Feb 05, 2021
The Physical Exam: Mitral Regurgitation This podcast episode tackles ascultation, vein inspection, heart palpation, pulse, and more Feb 05, 2021 podcast
Promising Tissue Valve Tech Blocks Calcium Buildup Zero structural valve deterioration at 5 Years in the COMMENCE study Feb 01, 2021
